198 related articles for article (PubMed ID: 8437240)
41. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
[TBL] [Abstract][Full Text] [Related]
42. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
[TBL] [Abstract][Full Text] [Related]
43. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.
Newberg MH; Kuroda MJ; Charini WA; Miura A; Lord CI; Schmitz JE; Gorgone DA; Lifton MA; Kuus-Reichel K; Letvin NL
Virology; 2002 Sep; 301(2):365-73. PubMed ID: 12359438
[TBL] [Abstract][Full Text] [Related]
44. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV.
Marthas ML; Sutjipto S; Higgins J; Lohman B; Torten J; Luciw PA; Marx PA; Pedersen NC
J Virol; 1990 Aug; 64(8):3694-700. PubMed ID: 2164591
[TBL] [Abstract][Full Text] [Related]
45. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Letvin NL
J Virol; 1996 Oct; 70(10):7335-40. PubMed ID: 8794394
[TBL] [Abstract][Full Text] [Related]
46. Bone marrow monocyte/macrophages are an early cellular target of pathogenic and nonpathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques.
Mandell CP; Jain NC; Miller CJ; Dandekar S
Lab Invest; 1995 Mar; 72(3):323-33. PubMed ID: 7898051
[TBL] [Abstract][Full Text] [Related]
47. Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis.
Yamamoto H; Miller MD; Watkins DI; Snyder GB; Chase NE; Mazzara GP; Gritz L; Panicali DL; Letvin NL
J Immunol; 1990 Dec; 145(11):3740-6. PubMed ID: 2147200
[TBL] [Abstract][Full Text] [Related]
48. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
Schmitz JE; Kuroda MJ; Santra S; Sasseville VG; Simon MA; Lifton MA; Racz P; Tenner-Racz K; Dalesandro M; Scallon BJ; Ghrayeb J; Forman MA; Montefiori DC; Rieber EP; Letvin NL; Reimann KA
Science; 1999 Feb; 283(5403):857-60. PubMed ID: 9933172
[TBL] [Abstract][Full Text] [Related]
49. Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys.
Schmitz JE; Kuroda MJ; Veazey RS; Seth A; Taylor WM; Nickerson CE; Lifton MA; Dailey PJ; Forman MA; Racz P; Tenner-Racz K; Letvin NL
J Immunol; 2000 Jun; 164(11):6015-9. PubMed ID: 10820285
[TBL] [Abstract][Full Text] [Related]
50. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
[TBL] [Abstract][Full Text] [Related]
51. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.
Chen ZW; Craiu A; Shen L; Kuroda MJ; Iroku UC; Watkins DI; Voss G; Letvin NL
J Immunol; 2000 Jun; 164(12):6474-9. PubMed ID: 10843704
[TBL] [Abstract][Full Text] [Related]
52. Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys.
Santra S; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Lord CI; Pal R; Franchini G; Letvin NL
J Immunol; 2002 Feb; 168(4):1847-53. PubMed ID: 11823518
[TBL] [Abstract][Full Text] [Related]
53. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
Yasutomi Y; Koenig S; Woods RM; Madsen J; Wassef NM; Alving CR; Klein HJ; Nolan TE; Boots LJ; Kessler JA
J Virol; 1995 Apr; 69(4):2279-84. PubMed ID: 7884874
[TBL] [Abstract][Full Text] [Related]
54. Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.
Nacsa J; Radaelli A; Edghill-Smith Y; Venzon D; Tsai WP; Morghen Cde G; Panicali D; Tartaglia J; Franchini G
Vaccine; 2004 Jan; 22(5-6):597-606. PubMed ID: 14741150
[TBL] [Abstract][Full Text] [Related]
55. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
[TBL] [Abstract][Full Text] [Related]
56. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.
Lohman BL; McChesney MB; Miller CJ; McGowan E; Joye SM; Van Rompay KK; Reay E; Antipa L; Pedersen NC; Marthas ML
J Virol; 1994 Nov; 68(11):7021-9. PubMed ID: 7933084
[TBL] [Abstract][Full Text] [Related]
57. Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251.
Stevceva L; Kelsall B; Nacsa J; Moniuszko M; Hel Z; Tryniszewska E; Franchini G
J Virol; 2002 Jan; 76(1):9-18. PubMed ID: 11739667
[TBL] [Abstract][Full Text] [Related]
58. Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239.
Genescà M; Rourke T; Li J; Bost K; Chohan B; McChesney MB; Miller CJ
J Immunol; 2007 Oct; 179(7):4732-40. PubMed ID: 17878372
[TBL] [Abstract][Full Text] [Related]
59. The repertoire of cytotoxic T lymphocytes in the recognition of mutant simian immunodeficiency virus variants.
Shen L; Chen ZW; Letvin NL
J Immunol; 1994 Dec; 153(12):5849-54. PubMed ID: 7989780
[TBL] [Abstract][Full Text] [Related]
60. Emergence of antigenic variants of simian immunodeficiency virus (SIVmac) in a seronegative macaque after SIVmac239 infection.
Chuang LF; Blackbourn DJ; Chuang AJ; Killam KF; Liu X; Li Y; Kung HF; Chuang RY
Cell Mol Biol Res; 1994; 40(7-8):661-9. PubMed ID: 7787884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
